Cargando…

Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results

PURPOSE: The purpose of this study was to evaluate the feasibility of radiofrequency ablation (RFA) for thyroid nodules with cytological atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS, Bethesda III). MATERIALS AND METHODS: A total of 28 adults present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Pi-Ling, Luo, Sheng-Dean, Chang, Yen-Hsiang, Chou, Chen-Kai, Chi, Shun-Yu, Chen, Yi-Fan, Lin, Wei-Che
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563608/ https://www.ncbi.nlm.nih.gov/pubmed/37695748 http://dx.doi.org/10.1530/ETJ-23-0105

Ejemplares similares

Efficacy of radiofrequency ablation for metastatic papillary thyroid cancer with and without initial biochemical complete status
por: Chen, Wen-Chieh, et al.
Publicado: (2022)

The Importance of Nodule Size in the Management of Ruptured Thyroid Nodule After Radiofrequency Ablation: A Retrospective Study and Literature Review
por: Chen, Wen-Chieh, et al.
Publicado: (2021)

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
por: Turkdogan, Sena, et al.
Publicado: (2020)

Evaluation of thyroid nodules classified as Bethesda category III on FNAC
por: Garg, Shiwani, et al.
Publicado: (2017)

Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III
por: Liu, Xiaoli, et al.
Publicado: (2022)

2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation
por: Lin, Wei-Che, et al.
Publicado: (2023)

The Ablation of Thyroid Nodule’s Afferent Arteries Before Radiofrequency Ablation: Preliminary Data
por: Offi, Chiara, et al.
Publicado: (2021)

The impact of thyroid imaging reporting and data system on the management of Bethesda III thyroid nodules()
por: Alqahtani, Saad M., et al.
Publicado: (2022)

Localization Strategy Prior to Radiofrequency Ablation for Primary and Secondary Hyperparathyroidism
por: Lee, Chih-Ying, et al.
Publicado: (2023)

Serum osteopontin can improve papillary thyroid cancer risk assessment of Bethesda III thyroid nodules: a preliminary study
por: Kars, T U, et al.
Publicado: (2021)

Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
por: Yoo, Mi Ri, et al.
Publicado: (2015)

The Role of “Critical” Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules
por: Orlando, Giuseppina, et al.
Publicado: (2023)

AI diagnosis of Bethesda category IV thyroid nodules
por: Yao, Jincao, et al.
Publicado: (2023)

Ultrasound-Guided Thermal Ablation of Bethesda IV Thyroid Nodules: A Pilot Study
por: Li, Xinyang, et al.
Publicado: (2021)

Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III
por: Huang, Jianhao, et al.
Publicado: (2021)

Hashimoto’s Thyroiditis Does Not Influence the Malignancy Risk in Nodules of Category III in the Bethesda System
por: Słowińska-Klencka, Dorota, et al.
Publicado: (2022)

An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules
por: Taccogna, Silvia, et al.
Publicado: (2022)

Malignancy in Thyroid Nodules with Bethesda III Category on Repeat Fine Needle Aspiration Biopsy*
por: Lourdes Ng, Jennifer, et al.
Publicado: (2023)

Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule
por: Li, Fu, et al.
Publicado: (2019)

Multicenter Study of Benign Thyroid Nodules with Radiofrequency Ablation: Results of 762 Cases over 4 Years in Taiwan
por: Lin, Wei-Che, et al.
Publicado: (2022)

Risk Stratification of Thyroid Nodules with Bethesda III Category: The Experience of a Territorial Healthcare Hospital
por: Al Dawish, Mohamed, et al.
Publicado: (2020)

Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: An institutional experience
por: Almahari, Sayed Ali, et al.
Publicado: (2019)

Strain Elastography as a Valuable Diagnosis Tool in Intermediate Cytology (Bethesda III) Thyroid Nodules
por: Stoian, Dana, et al.
Publicado: (2019)

Malignancy rates in thyroid nodules classified as Bethesda categories III and IV; a subcontinent perspective
por: Zahid, Adnan, et al.
Publicado: (2021)

Thyroid Cancer Detection Rate and Associated Risk Factors in Patients with Thyroid Nodules Classified As Bethesda Category III
por: Mileva, Magdalena, et al.
Publicado: (2018)

Malignancy Rate of Bethesda Class III Thyroid Nodules Based on the Presence of Chronic Lymphocytic Thyroiditis in Surgical Patients
por: Cho, Yoon Young, et al.
Publicado: (2021)

Association of patient characteristics, ultrasound features, and molecular testing with malignancy risk in Bethesda III–V thyroid nodules
por: Talmor, Guy, et al.
Publicado: (2022)

Radiofrequency Ablation a Safe and Effective Treatment for Pediatric Benign Nodular Thyroid Goiter
por: Lin, An-Ni, et al.
Publicado: (2021)

Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force
por: Ha, Eun Ju, et al.
Publicado: (2021)

Thyroid Nodules Cytopathology Applying the Bethesda System with Histopathological Correlation
por: Zarif, Hawazen A., et al.
Publicado: (2018)

Managing Bethesda IV thyroid nodules in an iodine-deficient population
por: Badash, Ido, et al.
Publicado: (2023)

Thermal Ablation for Benign Thyroid Nodules: Radiofrequency and Laser
por: Baek, Jung Hwan, et al.
Publicado: (2011)

Treatment Choices in Managing Bethesda III and IV Thyroid Nodules: A Canadian Multi-institutional Study
por: Kuta, Victoria, et al.
Publicado: (2021)

Association of thiol/disulphide homeostasis with Bethesda classification of thyroid nodules and thyroid cancer
por: BİLGİNER, Muhammet Cüneyt, et al.
Publicado: (2022)

Does Radiofrequency Ablation Induce Neoplastic Changes in Benign Thyroid Nodules: A Preliminary Study
por: Ha, Su Min, et al.
Publicado: (2019)

Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules
por: Tang, Xiaoyin, et al.
Publicado: (2017)

Risk Assessment and Hydrodissection Technique for Radiofrequency Ablation of Thyroid Benign Nodules
por: Xiaoyin, Tang, et al.
Publicado: (2018)

Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3
por: Kim, Na Eun, et al.
Publicado: (2023)

Malignancy rate of Bethesda category III thyroid nodules according to ultrasound risk stratification system and cytological subtype
por: Yoo, Won Sang, et al.
Publicado: (2020)

Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid Nodules
por: Hu, Mimi I, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pj6qu4n3cdp95ra8l62f8ptf0o